EXCEED THE SPACE PROVIDED. The overall objective of the research proposed in this grant application is to continue our analysis the molecular pathways that regulate B lineage commitment and maturation. Our studies would be focused on the regulation and function of a subset of helix-loop-helix proteins, named E-proteins, in B-lineage development. E-proteins, E12,E47, HEB and E2-2, function at multiple stages thorughout B cell development. Specifically, E-proteins act:(1) to activateB- lineage specific gene expression, (2)to control Ig light chain gene rearrangement, (3)toregulate receptor editing, (4) to enforce the developmental checkpoint at the immature-B cell stage, (5)to regulate marginal zone versus follicular zone B cell development and (6) to induce AID gene expression. During the next grant cycle we would continue these studies. In particular we would investigate the relationship involving E2A, EBF and Pax-5 in early B lineage development. We would examine how E2Aproteins activateand repress transcription and how they regulate Ig light chain gene rearrangement. We have recently demonstrated that theE2A proteins have the ability to repress transcription by recruitment of a transcriptional co-repressor, named ETO-2. We would examine the function of ETO-2 during B cell development and how the activity of ETO-2 is regulated. We have also recently determined using mass spectrometry two serine residues in E12and E47that are modifiedby phosphorylation and one lysine residue modified by methylation. We would introduce mutations in these residues and examine their impact on the activity of E2A both in vitro and in the mouse germ-line. We would further characterize the role of E-proteins in the regulation AID transcription. Overall the dissection of the roles of E2A in B cell development should help to clarify the mechanism by how E-proteins regulate Blineage maturation.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Method to Extend Research in Time (MERIT) Award (R37)
Project #
4R37CA054198-16
Application #
7118885
Study Section
Special Emphasis Panel (NSS)
Program Officer
Mccarthy, Susan A
Project Start
1991-04-01
Project End
2009-01-31
Budget Start
2006-02-01
Budget End
2007-01-31
Support Year
16
Fiscal Year
2006
Total Cost
$453,851
Indirect Cost
Name
University of California San Diego
Department
Biology
Type
Schools of Arts and Sciences
DUNS #
804355790
City
La Jolla
State
CA
Country
United States
Zip Code
92093
Miyazaki, Masaki; Miyazaki, Kazuko; Chen, Shuwen et al. (2014) Id2 and Id3 maintain the regulatory T cell pool to suppress inflammatory disease. Nat Immunol 15:767-76
Miyazaki, Kazuko; Miyazaki, Masaki; Murre, Cornelis (2014) The establishment of B versus T cell identity. Trends Immunol 35:205-10
Guo, Chunguang; Yoon, Hye Suk; Franklin, Andrew et al. (2011) CTCF-binding elements mediate control of V(D)J recombination. Nature 477:424-30
Mercer, Elinore M; Lin, Yin C; Benner, Christopher et al. (2011) Multilineage priming of enhancer repertoires precedes commitment to the B and myeloid cell lineages in hematopoietic progenitors. Immunity 35:413-25
Miyazaki, Masaki; Rivera, Richard R; Miyazaki, Kazuko et al. (2011) The opposing roles of the transcription factor E2A and its antagonist Id3 that orchestrate and enforce the naive fate of T cells. Nat Immunol 12:992-1001
Mercer, Elinore M; Lin, Yin C; Murre, Cornelis (2011) Factors and networks that underpin early hematopoiesis. Semin Immunol 23:317-25
Lin, Yin C; Jhunjhunwala, Suchit; Benner, Christopher et al. (2010) A global network of transcription factors, involving E2A, EBF1 and Foxo1, that orchestrates B cell fate. Nat Immunol 11:635-43
Roberts, V J; van Dijk, M A; Murre, C (1995) Localization of Pbx1 transcripts in developing rat embryos. Mech Dev 51:193-8
Bain, G; Maandag, E C; Izon, D J et al. (1994) E2A proteins are required for proper B cell development and initiation of immunoglobulin gene rearrangements. Cell 79:885-92
van Dijk, M A; Murre, C (1994) extradenticle raises the DNA binding specificity of homeotic selector gene products. Cell 78:617-24

Showing the most recent 10 out of 12 publications